These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2719846)

  • 1. Monitoring and evaluating psychotropic drug use for persons with mental retardation: a follow-up report.
    Briggs R
    Am J Ment Retard; 1989 May; 93(6):633-9. PubMed ID: 2719846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of interdisciplinary team review on psychotropic drug use with persons who have mental retardation.
    Findholt NE; Emmett CG
    Ment Retard; 1990 Feb; 28(1):41-6. PubMed ID: 2308511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A national study of prescribed drugs in institutions and community residential facilities for mentally retarded people.
    Hill BK; Balow EA; Bruininks RH
    Psychopharmacol Bull; 1985; 21(2):279-84. PubMed ID: 4001292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic medication of mentally retarded residents in community long-term care facilities.
    Buck JA; Sprague RL
    Am J Ment Retard; 1989 May; 93(6):618-23. PubMed ID: 2566316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of interdisciplinary team review on the use of antipsychotic agents with severely and profoundly mentally retarded persons.
    Glaser BA; Morreau LE
    Am J Ment Defic; 1986 Jan; 90(4):371-9. PubMed ID: 3946474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychoactive drug use in public and community residential facilities for mentally retarded persons.
    Intagliata J; Rinck C
    Psychopharmacol Bull; 1985; 21(2):268-78. PubMed ID: 4001291
    [No Abstract]   [Full Text] [Related]  

  • 7. Implementation of an interdisciplinary psychotropic drug review process for community-based facilities.
    Lepler S; Hodas A; Cotter-Mack A
    Ment Retard; 1993 Oct; 31(5):307-15. PubMed ID: 8271941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of psychotropic medication among individuals with mental retardation].
    Baasland G; Engedal K
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1751-3. PubMed ID: 19756056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How should mentally handicapped adults with depressive disorders be treated psychopharmacologically?].
    Meins W
    Nervenarzt; 1996 Mar; 67(3):216-8. PubMed ID: 8901279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychotropic medicines to patients with mental retardation].
    Bygdnes AM; Kristiansen A
    Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1028-30. PubMed ID: 17457386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
    Meins W; Auwetter J; Krausz M; Turnier Y
    Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of states' practices on the use of psychotropic medication.
    Rinck C; Guidry J; Calkins CF
    Am J Ment Retard; 1989 May; 93(6):657-68. PubMed ID: 2719848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment strategies for self-injurious behavior in a large service-delivery network.
    Altmeyer BK; Locke BJ; Griffin JC; Ricketts RW; Williams DE; Mason M; Stark MT
    Am J Ment Defic; 1987 Jan; 91(4):333-40. PubMed ID: 3812603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a psychotropic drug review service in a mental retardation facility.
    Marcoux AW
    Hosp Pharm; 1985 Nov; 20(11):827-31. PubMed ID: 10274172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and prediction of psychotropic drug use in California developmental centers.
    Stone RK; Alvarez WF; Ellman G; Hom AC; White JF
    Am J Ment Retard; 1989 May; 93(6):627-32. PubMed ID: 2719845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues in psychopharmacology with the mentally retarded.
    Mouchka S
    Psychopharmacol Bull; 1985; 21(2):262-7. PubMed ID: 4001290
    [No Abstract]   [Full Text] [Related]  

  • 17. Interdisciplinary team review of psychotropic drug use in community settings.
    Kastner TA; Walsh K
    Ment Retard; 1994 Jun; 32(3):243-5; discussion 245-7. PubMed ID: 8084278
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychotropic use in community residential care facilities: A prospective cohort study.
    Lakey SL; Gray SL; Sales AE; Sullivan J; Hedrick SC
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):227-35. PubMed ID: 17062323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The medical care of mentally retarded persons in public residential facilities.
    Nelson RP; Crocker AC
    N Engl J Med; 1978 Nov; 299(19):1039-44. PubMed ID: 703769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical pharmacy service to reduce psychotropic medication use in an institution for mentally handicapped persons.
    Inoue F
    Ment Retard; 1982 Apr; 20(2):70-4. PubMed ID: 7078402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.